Dupixent 300MG/2 ML 2S
Ended Awarded
- Contract number
- SPE2DR26FBCWS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,617
Award facts
- Contract value 100% obligated
- $35,616.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $35,616.84 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for Dupixent 300 mg/2 ml injectables. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of July 15, 2026, and was issued without a set-aside under the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract, which supports worldwide military healthcare supply across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FBCWS?
SPE2DR26FBCWS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26FBCWS worth?
The government has obligated $35,617 on SPE2DR26FBCWS.
Is contract SPE2DR26FBCWS an order under another contract?
Yes. SPE2DR26FBCWS is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBCWS competed?
The extent of competition for SPE2DR26FBCWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award